Drugs
Statistical Comparison of Mass Spectra for Identification of Amphetamine-type Stimulants
Intimate Partner Aggression-related Shame and Posttraumatic Stress Disorder Symptoms: The Moderating Role of Substance Use Problems
Chromatographic and mass spectral studies on methoxymethcathinones related to 3,4-methylenedioxymethamphetamine
Reversible and irreversible protein glutathionylation: biological and clinical aspects
Application of Snyder-Dolan classification scheme to the selection of "orthogonal" columns for fast screening of illicit drugs and impurity profiling of pharmaceuticals - I. Isocratic elution
Identification and Quantification of Synthetic Cathinones in Blood and Urine Using Liquid Chromatography-Quadrupole/Time of Flight (LC-Q/TOF) Mass Spectrometry
Mexico, the Failed State Debate, and the Merida Fix
WATCh: Montana's In-Prison DUI Treatment Program
Species Identification of Cannabis Sativa Using Real-Time Quantitative PCR (qPCR)
Methamphetamine and Violence in Illinois
Drug Abuse, Treatment, and Probationer Recidivism
Recovery Month: What We've Learned
Portraits of Recovery: Doreen Schenkenberger
Portraits of Recovery: David Gibbs
National Drug Court Month
What's Known and Unknown About Marijuana, Part 2
Marijuana legalization poses many challenges — especially those related to drug chemistry and toxicology — for researchers, law enforcement, and policy makers. In the latest episode of Justice Today, NIJ Communications Assistant Josh Mondoro hosts a conversation with NIJ Scientist Frances Scott about marijuana toxicology, including comparing its effects to alcohol, measuring impairment, and maintaining public safety as more and more states legalize recreational marijuana.